Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.
about
Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic reviewInfluence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients.Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients.Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium.Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Severe Enteropathy From Mycophenolate MofetilValidation of the cell line LS180 as a model for study of the gastrointestinal toxicity of mycophenolic acid.[Immunosuppression and its use in kidney transplantation].The Immunosuppressant Mycophenolic Acid Alters Nucleotide and Lipid Metabolism in an Intestinal Cell Model.Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.Mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant patients.Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
P2860
Q34365272-BF986B28-6A4F-4DB9-B779-100818B8DBC4Q35560664-52C3F762-B2BE-4DDF-9911-1B03FEF8E0DBQ35619332-E6103E65-FD59-476A-B45B-A5AACC9FDBD2Q36113293-8990087D-69ED-4523-94BB-3BBF60B81D9EQ37582505-CB12A3CD-C6F5-486D-AED4-7B831948C705Q37824708-6989F8C6-62FC-44D0-A9AD-287BFF743306Q38120321-31A23B52-342C-40A2-8167-F1500528A125Q38208983-2EF2773D-4926-43F0-B055-D002AF8077FEQ38332431-8D84C619-87FD-425F-9977-BEC5C8E84409Q38704055-0AF0CA56-8955-497C-AA15-195622FF0A34Q40956126-DFC0A955-CE76-416D-91F1-229885D0677DQ41768816-B0C43715-55C1-4EA4-9E8E-72CDF03179D9Q44024686-0A6FDF7B-0752-4B04-A11B-6C864DDB85CFQ46048838-1A6B1700-FCE7-49A4-BC23-26AC79809243Q53791202-7F901182-9D66-437E-AB0A-FE85FC8761D0
P2860
Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@en
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@nl
type
label
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@en
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@nl
prefLabel
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@en
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@nl
P1476
Impact of gastrointestinal-rel ...... ential therapeutic strategies.
@en
P2093
Patrice M Ambühl
Suphamai Bunnapradist
P304
P356
10.1111/J.1399-0012.2008.00892.X
P577
2008-09-16T00:00:00Z